^Investigational New Drug Toxicology for Drugs to Treat AD & Other Aging-Related
^Investigational New Drug Toxicology for Drugs to Treat AD & Other Aging-Related
批准号:
8338716
负责人:
KAREN STEINMETZ
金额:
$16.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-16 至 2011-12-31
关键词:
AgingAlzheimer disease preventionAlzheimer&aposs DiseaseAmyloid beta-ProteinAnalytical ChemistryAnimal TestingBasic ScienceBiological AvailabilityBrainBusinessesCategoriesClinical ResearchClinical TrialsComplementContractsDataDevelopmentDiseaseDisease ProgressionDrug KineticsEvaluationGrantHumanImageImpaired cognitionIndividualInvestigational DrugsNational Institute on AgingOsteoporosisPharmaceutical PreparationsPharmacologyPharmacotherapyPositron-Emission TomographyPreclinical Drug DevelopmentProcessResearchResearch PersonnelResourcesSafetyScreening procedureServicesSymptomsTestingToxic effectToxicologyTranslatingUnited States Food and Drug Administrationage relateddrug discoverydrug mechanismfallspre-clinicalpreventprograms
中文摘要
开发和测试治疗与阿尔茨海默病(AD)相关的认知障碍的新药是美国国家衰老研究所(NIA)的一项主要计划活动,但目前由于许多研究人员无法进入动物试验设施而受到阻碍。由于目前缺乏能够一致地减缓或逆转疾病进展、改善症状或预防疾病的任何化合物,因此需要尽一切努力促进新化合物的开发和测试。开发其他与衰老有关的疾病(如骨质疏松症)的化合物的必要性也很明显。此外,用于评估AD脑β -淀粉样蛋白和其他病理生理特征的正电子发射断层扫描(PET)显像剂的出现需要在人体研究之前对这些药物进行毒理学测试。
英文摘要
Efforts in developing and testing new drugs for the treatment of the cognitive impairment associated with Alzheimer's disease (AD) represent a major programmatic activity of the National Institute on Aging (NIA) but are now hindered by the lack of access of many investigators to animal testing facilities. The present paucity of any compounds which can uniformly slow or reverse the progression of the disease, ameliorate the symptoms, or prevent the disease requires that every effort be made to facilitate the development and testing of new compounds. The need to develop compounds for other aging related diseases such as osteoporosis is also apparent. Additionally, the advent of Positron Emission Tomography (PET) imaging agents for assessing brain beta-amyloid and other pathophysiological features of AD requires toxicological testing of these agents prior to human studies.
However, there are still gaps in our overall effort to facilitate the development and testing of new compounds. Specifically, resources are needed by investigators who are developing new compounds so that the potential adverse toxicological activity of the compounds can be evaluated before they can be taken into clinical trials. This is a very expensive process and is beyond the resources of almost all investigators. NIA program staff have been contacted by investigators who have compounds that they believe seem promising for the treatment of Alzheimer's disease and that they would like to take into clinical trials, but they do not have the resources to have the mandatory toxicological screening done.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOLOGICAL TESTING FACILITY - DMAU CLINICAL SUPPLIES AND STABILITY TESTING OF DMAU CAPSULES
-
批准号:8937289
-
项目类别:
-
资助金额:$100.4万
-
财政年份:2012
-
负责人:KAREN STEINMETZ
-
依托单位:
BIOLOGICAL TESTING FACILITY
-
批准号:8937275
-
项目类别:
-
资助金额:$65.0万
-
财政年份:2012
-
负责人:KAREN STEINMETZ
-
依托单位:
Alcohol and Epidemiological Data System (AEDS)
-
批准号:8328311
-
项目类别:
-
资助金额:$0.87万
-
财政年份:2010
-
负责人:KAREN STEINMETZ
-
依托单位:
BIOLOGICAL TESTING FACILITY FOR CRH
-
批准号:7947217
-
项目类别:
-
资助金额:$305.38万
-
财政年份:2009
-
负责人:KAREN STEINMETZ
-
依托单位:
PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR MEDICATIONS DEVELOPMENT
-
批准号:8335334
-
项目类别:
-
资助金额:$38.4万
-
财政年份:2006
-
负责人:KAREN STEINMETZ
-
依托单位:
Modeling Immunity for Biodefense
-
批准号:8335364
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2005
-
负责人:KAREN STEINMETZ
-
依托单位:
Task D21: Evaluation of Orthopox Vaccination
-
批准号:8328365
-
项目类别:
-
资助金额:$41.45万
-
财政年份:2004
-
负责人:KAREN STEINMETZ
-
依托单位:
INVESTIGATIONAL NEW DRUG TOXICOLOGY FOR DRUGS TO TREAT ALZHEIMER'S DISEASE AND O
-
批准号:7543825
-
项目类别:
-
资助金额:$129.25万
-
财政年份:2004
-
负责人:KAREN STEINMETZ
-
依托单位:--
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
-
批准号:8335323
-
项目类别:
-
资助金额:$27.77万
-
财政年份:1992
-
负责人:KAREN STEINMETZ
-
依托单位:
Investigational New Drug Toxicology for Drugs to Treat Alzheimer's Disease and Ot
-
批准号:8340929
-
项目类别:
-
资助金额:$23.84万
-
财政年份:--
-
负责人:KAREN STEINMETZ
-
依托单位:
Investigational New Drug Toxicology for Drugs to Treat Alzheimer's Disease and Ot
-
批准号:8340932
-
项目类别:
-
资助金额:$14.48万
-
财政年份:--
-
负责人:KAREN STEINMETZ
-
依托单位:
Investigational New Drug Toxicology for Drugs to Treat Alzheimer's Disease and Ot
-
批准号:8340930
-
项目类别:
-
资助金额:$39.32万
-
财政年份:--
-
负责人:KAREN STEINMETZ
-
依托单位:
Investigational New Drug Toxicology for Drugs to Treat Alzheimer's Disease and Ot
-
批准号:8340931
-
项目类别:
-
资助金额:$15.29万
-
财政年份:--
-
负责人:KAREN STEINMETZ
-
依托单位:
海外基金